am 251 has been researched along with Psychotic Disorders in 2 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlén, A | 1 |
| Zarei, M | 1 |
| Melgoza, A | 1 |
| Wagle, M | 1 |
| Guo, S | 1 |
| Zamberletti, E | 1 |
| Viganò, D | 1 |
| Guidali, C | 1 |
| Rubino, T | 1 |
| Parolaro, D | 1 |
2 other studies available for am 251 and Psychotic Disorders
| Article | Year |
|---|---|
THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dronabinol; N-Methylaspartate; Piperidines; Psych | 2021 |
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.
Topics: Acute Disease; Animals; Antipsychotic Agents; Cannabinoids; Interpersonal Relations; Male; Piperidin | 2012 |